Saint Luc Valve Registry (SaLVaRe)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02974218|
Recruitment Status : Recruiting
First Posted : November 28, 2016
Last Update Posted : November 28, 2016
The Cliniques Universitaires Saint Luc are one of the high specialized center in valvular heart diseases and valvular heart surgery. Aortic stenosis, mitral and aortic regurgitation are the three valve pathology that are mainly frequent and studied.
International guidelines in the management of valvular heart diseases are based on few limited old studies, mainly retrospective. And, a matter of concern is staying, about the timiong of surgery for asymptomatic patients.
A prospective registry will help us to better understand the pathologies and try to better define guidelines criteria for surgery.
|Condition or disease|
|Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)|
With this prospective registry, all patients with aortic stenosis, mitral and aortic regurgitation will be followed. We will find followed patients not yet operated or until surgery, but also patient after surgery according to the presence or abscence of guidelines criteria.
It will permit to compare different kind of management of patients with valvular heart disease and to better define guidelines criteria for surgery.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||5000 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Saint Luc Valve Registry|
|Study Start Date :||January 2000|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||January 2025|
- Overall survival [ Time Frame: every two years up to 10 years ]From the date of the first echocardiography until the date of death from any cause, doumented progression and surgery will be regularly assessed up to 10 years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02974218
|Contact: de Meester Christophe, PhD||003227642816 ext firstname.lastname@example.org|
|Cliniques Universitaires Saint Luc - Université Catholique de Louvain||Recruiting|
|Brussels, Belgium, 1200|
|Contact: de Meester Christophe, PhD 003227642816 ext 42816 email@example.com|
|Study Director:||Vanoverschlde Jean-Louis, MD, PhD||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|